79 related articles for article (PubMed ID: 3259467)
1. Transferrin-like autocrine growth factor, derived from T-lymphoma cells, that inhibits normal T-cell proliferation.
Morrone G; Corbo L; Turco MC; Pizzano R; De Felice M; Bridges S; Venuta S
Cancer Res; 1988 Jun; 48(12):3425-9. PubMed ID: 3259467
[TBL] [Abstract][Full Text] [Related]
2. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
[TBL] [Abstract][Full Text] [Related]
3. Secretion of a novel T-lymphocyte cytokine possessing both chemotactic and growth factor activity by serotonin-stimulated human aortic endothelial cells.
Katz MF; Beer DJ; Duquette D; Cruikshank WW; Antonov AS; Romanov YA; Smirnov VN; Farber HW
Exp Cell Res; 1994 May; 212(1):113-9. PubMed ID: 8174633
[TBL] [Abstract][Full Text] [Related]
4. Development of a serum-free medium which supports the long-term growth of human and nonhuman primate lymphoid cells.
Brown RL; Griffith RL; Neubauer RH; Rabin H
J Cell Physiol; 1983 May; 115(2):191-8. PubMed ID: 6341383
[TBL] [Abstract][Full Text] [Related]
5. A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1.
Dao T; Holán V; Minowada J
Neoplasma; 1993; 40(5):265-73. PubMed ID: 8272154
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-like activity produced by murine malignant T-lymphoma cell lines.
Kitada S; Hays EF
Cancer Res; 1985 Aug; 45(8):3537-40. PubMed ID: 2990673
[TBL] [Abstract][Full Text] [Related]
7. The role of the transferrin receptor in human B lymphocyte activation.
Neckers LM; Yenokida G; James SP
J Immunol; 1984 Nov; 133(5):2437-41. PubMed ID: 6090534
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype.
Gjerset RA; Yeargin J; Volkman SK; Vila V; Arya J; Haas M
J Immunol; 1990 Nov; 145(10):3497-501. PubMed ID: 2230132
[TBL] [Abstract][Full Text] [Related]
9. Role of heme-hemopexin in human T-lymphocyte proliferation.
Smith A; Eskew JD; Borza CM; Pendrak M; Hunt RC
Exp Cell Res; 1997 May; 232(2):246-54. PubMed ID: 9168799
[TBL] [Abstract][Full Text] [Related]
10. Effect of rous sarcoma virus transformation of rat-1 fibroblasts upon their growth factor and anchorage requirements in serum-free medium.
Giguère L; Gospodarowicz D
Cancer Res; 1983 May; 43(5):2121-30. PubMed ID: 6299541
[TBL] [Abstract][Full Text] [Related]
11. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
13. The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone.
Cox JH; Lamb JR; Bal V; Butcher GW; Howard JC; Owen MJ; Ivanyi J
Immunology; 1989 Jan; 66(1):83-9. PubMed ID: 15493267
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
Gillis S; Scheid M; Watson J
J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
[TBL] [Abstract][Full Text] [Related]
15. Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor.
Santoli D; Clark SC; Kreider BL; Maslin PA; Rovera G
J Immunol; 1988 Jul; 141(2):519-26. PubMed ID: 3290340
[TBL] [Abstract][Full Text] [Related]
16. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell growth factor: parameters for production.
Ruscetti FW; Mier JW; Gallo RC
J Supramol Struct; 1980; 13(2):229-41. PubMed ID: 6972470
[TBL] [Abstract][Full Text] [Related]
18. Plasma inter-alpha-trypsin inhibitor-related urinary glycoprotein EDC1 inhibits the growth of a Burkitt's lymphoma cell line.
Chawla RK; Lawson DH; Travis J
J Cell Biochem; 1990 Apr; 42(4):207-17. PubMed ID: 1692840
[TBL] [Abstract][Full Text] [Related]
19. Cells of T-lymphocyte origin produce an erythropoietin-like growth factor.
Fagg B; Engers HD
Exp Hematol; 1986 Dec; 14(11):1006-10. PubMed ID: 3490989
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA.
Arya SK; Wong-Staal F; Gallo RC
J Immunol; 1984 Jul; 133(1):273-6. PubMed ID: 6427338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
